Brenig Therapeutics
PrivateLast Round
Series A
Jul 23, 2024
Total Funding Raised
$73M
Momentum Score
50 /100
Company Overview
Brenig Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative small-molecule therapies for neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brenig Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Brenig Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 23, 2024 | ||||
| Seed | Apr 29, 2021 |
Key People
Founding team and executive leadership
Brenig Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Series A, Seed |
| Torrey Pines Investment LLC | Series A, Seed |
| i2020 Accelerator | Seed |
| BioGeneration Ventures | Series A, Seed |
| New Enterprise Associates | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Balloon constellation quadrupled in size over the past year.
- Apr 1, 2026
Launched Amslah, a custom open source RTOS hardware abstraction layer.
Brenig Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Brenig Therapeutics's valuation, stock price, and market status.
